Recordati Industria Chimica e Farmaceutica S.p.A. (REC.VI)

UPDATE 1-CVC explores options for Italy's Recordati, Bloomberg News reports

CVC Capital Partners is exploring options for its controlling stake in Italian pharmaceutical group Recordati SpA, Bloomberg News reported on Tuesday, citing people familiar with the matter. CVC and Recordati did not immediately respond to a Reuters request for comments. A CVC-led consortium of investment funds had agreed to buy 51.8% of Recordati in a deal worth about 3 billion euros in 2018.